Literature DB >> 27624384

High-Intensity Swimming Exercise Decreases Glutamate-Induced Nociception by Activation of G-Protein-Coupled Receptors Inhibiting Phosphorylated Protein Kinase A.

Daniel F Martins1, Aline Siteneski2, Daniela D Ludtke2, Daniela Dal-Secco3, Adair R S Santos3.   

Abstract

Several studies in humans have reported that improved pain control is associated with exercise in a variety of painful conditions, including osteoarthritis, fibromyalgia, and neuropathic pain. Despite the growing amount of experimental data on physical exercise and nociception, the precise mechanisms through which high-intensity exercise reduces pain remain elusive. Since the glutamatergic system plays a major role in pain transmission, we firstly analyzed if physical exercise could be able to decrease glutamate-induced nociception through G-protein-coupled receptor (G-PCR) activation. The second purpose of this study was to examine the effect of exercising upon phosphorylation of protein kinase A (PKA) isoforms induced by intraplantar (i.pl.) glutamate injection in mice. Our results demonstrate that high-intensity swimming exercise decreases nociception induced by glutamate and that i.pl. or intrathecal injections of cannabinoid, opioid, and adenosine receptor antagonists, AM281, naloxone, and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), respectively, prevent this effect. Furthermore, the peripheral A1 and opioid receptors, but not CB1, are also involved in exercise's effect. We also verified that glutamate injection increases levels of phosphorylated PKA (p-PKA). High-intensity swimming exercise significantly prevented p-PKA increase. The current data show the direct involvement of the glutamatergic system on the hyponociceptive effect of high-intensity swimming exercise as well as demonstrate that physical exercise can activate multiple intracellular pathways through G-PCR activation, which share the same endogenous mechanism, i.e., inhibition of p-PKA.

Entities:  

Keywords:  Adenosine; Cannabinoid; Glutamate; Nociception; Opioid; Physical activity

Mesh:

Substances:

Year:  2016        PMID: 27624384     DOI: 10.1007/s12035-016-0095-9

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  69 in total

1.  Afferent C-fibres release substance P and glutamate.

Authors:  I Juránek; F Lembeck
Journal:  Can J Physiol Pharmacol       Date:  1997-06       Impact factor: 2.273

2.  The nociception induced by glutamate in mice is potentiated by protons released into the solution.

Authors:  Flavia Carla Meotti; Igor dos Santos Coelho; Adair Roberto Soares Santos
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

3.  Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.

Authors:  Cheryl L Marker; Rafael Luján; Horace H Loh; Kevin Wickman
Journal:  J Neurosci       Date:  2005-04-06       Impact factor: 6.167

4.  Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw.

Authors:  Alessandra Beirith; Adair R S Santos; João B Calixto
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

5.  Peripheral and spinal activation of cannabinoid receptors by joint mobilization alleviates postoperative pain in mice.

Authors:  D F Martins; L Mazzardo-Martins; F J Cidral-Filho; V M Gadotti; A R S Santos
Journal:  Neuroscience       Date:  2013-10-10       Impact factor: 3.590

6.  A runner's high depends on cannabinoid receptors in mice.

Authors:  Johannes Fuss; Jörg Steinle; Laura Bindila; Matthias K Auer; Hartmut Kirchherr; Beat Lutz; Peter Gass
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

7.  Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids.

Authors:  Nicola J Stagg; Heriberto P Mata; Mohab M Ibrahim; Erik J Henriksen; Frank Porreca; Todd W Vanderah; T Philip Malan
Journal:  Anesthesiology       Date:  2011-04       Impact factor: 7.892

8.  Mouse Phenome Project: understanding human biology through mouse genetics and genomics.

Authors:  Molly Bogue
Journal:  J Appl Physiol (1985)       Date:  2003-10

Review 9.  Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept.

Authors:  G A Brooks; J Mercier
Journal:  J Appl Physiol (1985)       Date:  1994-06

Review 10.  Exercise for treating fibromyalgia syndrome.

Authors:  A J Busch; K A R Barber; T J Overend; P M J Peloso; C L Schachter
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more
  5 in total

1.  Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery.

Authors:  Huifeng Pi; Mengyu Liu; Yu Xi; Mengyan Chen; Li Tian; Jia Xie; Mingliang Chen; Zhen Wang; Min Yang; Zhengping Yu; Zhou Zhou; Feng Gao
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

2.  The role of spinal inhibitory neuroreceptors in the antihyperalgesic effect of warm water immersion therapy.

Authors:  Fernanda Madeira; Rômulo Nolasco de Brito; Aline A Emer; Ana Paula Batisti; Bruna Lenfers Turnes; Afonso Shiguemi Inoue Salgado; Francisco José Cidral-Filho; Leidiane Mazzardo-Martins; Daniel Fernandes Martins
Journal:  Braz J Phys Ther       Date:  2020-02-12       Impact factor: 3.377

Review 3.  Does exercise increase or decrease pain? Central mechanisms underlying these two phenomena.

Authors:  Lucas V Lima; Thiago S S Abner; Kathleen A Sluka
Journal:  J Physiol       Date:  2017-05-26       Impact factor: 5.182

Review 4.  Chronic Pain in Musculoskeletal Diseases: Do You Know Your Enemy?

Authors:  Roberto Bonanni; Ida Cariati; Virginia Tancredi; Riccardo Iundusi; Elena Gasbarra; Umberto Tarantino
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

Review 5.  Mechanism of exercise-induced analgesia: what we can learn from physically active animals.

Authors:  Joseph B Lesnak; Kathleen A Sluka
Journal:  Pain Rep       Date:  2020-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.